(Q93718080)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4110641%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

title

Evaluation of clonidine in prophylaxis of migraine. Double-blind trial and follow-up (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4110641%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

author name string

J Shafar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4110641%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

E R Tallett

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4110641%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

P A Knowlson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4110641%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

publication date

1 February 1972

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4110641%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4110641%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4110641%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

page(s)

403-407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4110641%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

issue

7747

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4110641%20AND%20SRC:MED&resulttype=core&format=json

Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan)

9 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990855-0

7 January 2021

Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HCl.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990855-0

7 January 2021

A possible pharmacological approach to migraine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990855-0

7 January 2021

Clinical and clinical-experimental studies with a new blood pressure lowering substance: dichlorophenylaminoimidazoline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990855-0

7 January 2021

Circulatory effects at rest and exercise of clonidine, an imidazoline derivative with hypotensive properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990855-0

7 January 2021

Treatment of Hypertension with Clonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990855-0

7 January 2021

The Treatment of Benign Hypertension with Clonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990855-0

7 January 2021

Clonidine for migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990855-0

7 January 2021

2-(2.6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155 or Catapresan) as a prophylactic remedy against migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2872%2990855-0

7 January 2021

10.1016/S0140-6736(72)90855-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4110641%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

1 reference